Analgesics
Antiandrogens
Azvudine
Bromhexine
Budesonide
Colchicine
Conv. Plasma
Curcumin
Famotidine
Favipiravir
Fluvoxamine
Hydroxychlor..
Ivermectin
Lifestyle
Melatonin
Metformin
Minerals
Molnupiravir
Monoclonals
Naso/orophar..
Nigella Sativa
Nitazoxanide
Paxlovid
Quercetin
Remdesivir
Thermotherapy
Vitamins
More

Other
Feedback
Home
Top
Abstract
All povidone‑iodine studies
Meta analysis
 
Feedback
Home
next
study
previous
study
c19early.org COVID-19 treatment researchPVP-IPovidone-Iod.. (more..)
Melatonin Meta
Metformin Meta
Azvudine Meta
Bromhexine Meta Molnupiravir Meta
Budesonide Meta
Colchicine Meta
Conv. Plasma Meta Nigella Sativa Meta
Curcumin Meta Nitazoxanide Meta
Famotidine Meta Paxlovid Meta
Favipiravir Meta Quercetin Meta
Fluvoxamine Meta Remdesivir Meta
Hydroxychlor.. Meta Thermotherapy Meta
Ivermectin Meta

All Studies   Meta Analysis    Recent:   

Is povidone iodine mouthwash effective against SARS-CoV-2? First in vivo tests

Martínez Lamas et al., Oral Diseases, doi:10.1111/odi.13526
Jul 2020  
  Post
  Facebook
Share
  Source   PDF   All Studies   Meta AnalysisMeta
PVP-I for COVID-19
12th treatment shown to reduce risk in February 2021
 
*, now known with p = 0.000000004 from 21 studies.
Lower risk for mortality, cases, and viral clearance.
No treatment is 100% effective. Protocols combine complementary and synergistic treatments. * >10% efficacy in meta analysis with ≥3 clinical studies.
4,200+ studies for 60+ treatments. c19early.org
Small study analyzing the impact of PVP-I mouthwash on the salivary viral load of SARS-CoV-2 in 4 patients with COVID-19. In 2 of the 4 patients (those with a higher initial viral load), PVP-I resulted in a significant drop in viral load, which remained after 3 hours.
Martínez Lamas et al., 2 Jul 2020, peer-reviewed, 9 authors.
This PaperPovidone-Iod..All
Abstract: Received: 11 June 2020 | Revised: 22 June 2020 | Accepted: 22 June 2020 DOI: 10.1111/odi.13526 S H O R T C O M M U N I C AT I O N Is povidone iodine mouthwash effective against SARS-CoV-2? First in vivo tests Lucía Martínez Lamas1 | Pedro Diz Dios2 | Maria Teresa Pérez Rodríguez3 | Victor Del Campo Pérez4 | Jorge Julio Cabrera Alvargonzalez1 | Ana María López Domínguez3 | Javier Fernandez Feijoo2 | Marcio Diniz Freitas2 | Jacobo Limeres Posse2 1 Department of Microbiology, Microbiology and Infectology Research Group, Galicia Sur Health Research Institute (IIS Galicia Sur) SERGAS-Universidade de Vigo, Complexo Hospitalario Universitario de Vigo (CHUVI), Sergas, Vigo, Spain 2 Medical-Surgical Dentistry Research Group (OMEQUI), Health Research Institute of Santiago de Compostela (IDIS), University of Santiago de Compostela (USC), Santiago de Compostela, Spain 3 Internal Medicine Department, Infectious Diseases Unit, Complexo Hospitalario Universitario de Vigo (CHUVI), Galicia Sur Health Research Institute (IIS Galicia Sur) SERGAS-Universidade de Vigo, Vigo, Spain 4 Preventive Medicine Department, Complexo Hospitalario Universitario de Vigo (CHUVI), Sergas, Vigo, Spain Correspondence: Pedro Diz Dios, Department of Surgery and Medical-Surgical Specialties, Faculty of Medicine and Odontology, University of Santiago de Compostela, c/Entrerríos sn, 15782 Santiago de Compostela, Spain. Email: pedro.diz@usc.es Keywords: aerosol, coronavirus, COVID-19, mouthwash, povidone iodine, SARS-CoV-2 1 | I NTRO D U C TI O N transmission of this new coronavirus? To date, the efficacy of povidone against SARS-CoV-2 has not been confirmed. In this study, we The detection of SARS-CoV-2 in the saliva of patients with coro- analyzed the impact of a mouthwash with PVP-I on the salivary viral navirus disease (COVID-19) has made this biological fluid relevant load of SARS-CoV-2 in 4 patients with COVID-19. in terms of the diagnosis and transmission of the infection (Azzi, Carcano, Gianfagna, et al., 2020; To, Tsang, Yip, et al., 2020). As a result, the dental clinic is considered an environment of risk for dental healthcare personnel and their patients, particularly due to the potential transmission of the virus through droplets and aerosols 2 | M E TH O DS 2.1 | Patient 1 (Peng et al., 2020). Based on this argument, it has been suggested that the measures for controlling cross-infection during dental prac- A 74-year-old man with a history of B-cell non-Hodgkin's lymphoma tice should include a preprocedural mouth rinse containing oxida- was admitted to the hospital 28 days ago due to pneumonia by tive agents such as 1% hydrogen peroxide and 0.2% povidone iodine SARS-CoV-2. The patient underwent treatment with hydroxychlo- (PVP-I) (Peng et al., 2020). This protocol, with small variations, has roquine, lopinavir + ritonavir, corticosteroids, and tocilizumab. The been accepted by the main professional dental associations world- patient required admission to the intensive care unit and endotra- wide, such as the American Dental Association (ADA, 2020). If an cheal intubation. The patient is currently hospitalized in the hospital antiseptic mouthwash's virucidal activity is demonstrated, why ward, without exogenous oxygen supply, is undergoing treatment limit its application to the dental clinic setting and not adminis- with rituximab, and presents positive serial polymerase chain reac- ter it routinely to the entire population to..
{ 'DOI': '10.1111/odi.13526', 'ISSN': ['1354-523X', '1601-0825'], 'URL': 'http://dx.doi.org/10.1111/odi.13526', 'alternative-id': ['10.1111/odi.13526'], 'assertion': [ { 'group': {'label': 'Publication History', 'name': 'publication_history'}, 'label': 'Received', 'name': 'received', 'order': 0, 'value': '2020-06-11'}, { 'group': {'label': 'Publication History', 'name': 'publication_history'}, 'label': 'Accepted', 'name': 'accepted', 'order': 1, 'value': '2020-06-22'}, { 'group': {'label': 'Publication History', 'name': 'publication_history'}, 'label': 'Published', 'name': 'published', 'order': 2, 'value': '2020-07-29'}], 'author': [ { 'affiliation': [ { 'name': 'Department of Microbiology Microbiology and Infectology Research ' 'Group Galicia Sur Health Research Institute (IIS Galicia Sur) ' 'SERGAS‐Universidade de Vigo Complexo Hospitalario Universitario ' 'de Vigo (CHUVI) Sergas, Vigo Spain'}], 'family': 'Martínez Lamas', 'given': 'Lucía', 'sequence': 'first'}, { 'ORCID': 'http://orcid.org/0000-0002-1483-401X', 'affiliation': [ { 'name': 'Medical‐Surgical Dentistry Research Group (OMEQUI) Health ' 'Research Institute of Santiago de Compostela (IDIS) University ' 'of Santiago de Compostela (USC) Santiago de Compostela Spain'}], 'authenticated-orcid': False, 'family': 'Diz Dios', 'given': 'Pedro', 'sequence': 'additional'}, { 'affiliation': [ { 'name': 'Internal Medicine Department Infectious Diseases Unit Complexo ' 'Hospitalario Universitario de Vigo (CHUVI) Galicia Sur Health ' 'Research Institute (IIS Galicia Sur) SERGAS‐Universidade de ' 'Vigo Vigo Spain'}], 'family': 'Pérez Rodríguez', 'given': 'Maria Teresa', 'sequence': 'additional'}, { 'affiliation': [ { 'name': 'Preventive Medicine Department Complexo Hospitalario ' 'Universitario de Vigo (CHUVI) Sergas, Vigo Spain'}], 'family': 'Del Campo Pérez', 'given': 'Victor', 'sequence': 'additional'}, { 'affiliation': [ { 'name': 'Department of Microbiology Microbiology and Infectology Research ' 'Group Galicia Sur Health Research Institute (IIS Galicia Sur) ' 'SERGAS‐Universidade de Vigo Complexo Hospitalario Universitario ' 'de Vigo (CHUVI) Sergas, Vigo Spain'}], 'family': 'Cabrera Alvargonzalez', 'given': 'Jorge Julio', 'sequence': 'additional'}, { 'affiliation': [ { 'name': 'Internal Medicine Department Infectious Diseases Unit Complexo ' 'Hospitalario Universitario de Vigo (CHUVI) Galicia Sur Health ' 'Research Institute (IIS Galicia Sur) SERGAS‐Universidade de ' 'Vigo Vigo Spain'}], 'family': 'López Domínguez', 'given': 'Ana María', 'sequence': 'additional'}, { 'affiliation': [ { 'name': 'Medical‐Surgical Dentistry Research Group (OMEQUI) Health ' 'Research Institute of Santiago de Compostela (IDIS) University ' 'of Santiago de Compostela (USC) Santiago de Compostela Spain'}], 'family': 'Fernandez Feijoo', 'given': 'Javier', 'sequence': 'additional'}, { 'affiliation': [ { 'name': 'Medical‐Surgical Dentistry Research Group (OMEQUI) Health ' 'Research Institute of Santiago de Compostela (IDIS) University ' 'of Santiago de Compostela (USC) Santiago de Compostela Spain'}], 'family': 'Diniz Freitas', 'given': 'Marcio', 'sequence': 'additional'}, { 'affiliation': [ { 'name': 'Medical‐Surgical Dentistry Research Group (OMEQUI) Health ' 'Research Institute of Santiago de Compostela (IDIS) University ' 'of Santiago de Compostela (USC) Santiago de Compostela Spain'}], 'family': 'Limeres Posse', 'given': 'Jacobo', 'sequence': 'additional'}], 'container-title': 'Oral Diseases', 'container-title-short': 'Oral Diseases', 'content-domain': {'crossmark-restriction': True, 'domain': ['onlinelibrary.wiley.com']}, 'created': {'date-parts': [[2020, 7, 2]], 'date-time': '2020-07-02T21:09:30Z', 'timestamp': 1593724170000}, 'deposited': { 'date-parts': [[2023, 8, 25]], 'date-time': '2023-08-25T19:07:02Z', 'timestamp': 1692990422000}, 'indexed': {'date-parts': [[2024, 5, 9]], 'date-time': '2024-05-09T21:12:30Z', 'timestamp': 1715289150921}, 'is-referenced-by-count': 68, 'issue': 'S1', 'issued': {'date-parts': [[2020, 7, 29]]}, 'journal-issue': {'issue': 'S1', 'published-print': {'date-parts': [[2022, 4]]}}, 'language': 'en', 'license': [ { 'URL': 'http://onlinelibrary.wiley.com/termsAndConditions#vor', 'content-version': 'vor', 'delay-in-days': 0, 'start': { 'date-parts': [[2020, 7, 29]], 'date-time': '2020-07-29T00:00:00Z', 'timestamp': 1595980800000}}], 'link': [ { 'URL': 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fodi.13526', 'content-type': 'application/pdf', 'content-version': 'vor', 'intended-application': 'text-mining'}, { 'URL': 'https://onlinelibrary.wiley.com/doi/pdf/10.1111/odi.13526', 'content-type': 'application/pdf', 'content-version': 'vor', 'intended-application': 'text-mining'}, { 'URL': 'https://onlinelibrary.wiley.com/doi/full-xml/10.1111/odi.13526', 'content-type': 'application/xml', 'content-version': 'vor', 'intended-application': 'text-mining'}, { 'URL': 'https://onlinelibrary.wiley.com/doi/pdf/10.1111/odi.13526', 'content-type': 'unspecified', 'content-version': 'vor', 'intended-application': 'similarity-checking'}], 'member': '311', 'original-title': [], 'page': '908-911', 'prefix': '10.1111', 'published': {'date-parts': [[2020, 7, 29]]}, 'published-online': {'date-parts': [[2020, 7, 29]]}, 'published-print': {'date-parts': [[2022, 4]]}, 'publisher': 'Wiley', 'reference': [ { 'key': 'e_1_2_7_2_1', 'unstructured': 'ADA Interim Guidance for Minimizing Risk of COVID‐19 ' 'Transmission.https://www.ada.org/~/media/CPS/Files/COVID/ADA_COVID_Int_Guidance_Treat_Pts.pdf. ' 'Accessed May 10 2020'}, { 'article-title': 'Two cases of COVID‐19 with positive salivary and negative pharyngeal or ' 'respiratory swabs at hospital discharge: A rising concern', 'author': 'Azzi L.', 'first-page': '1', 'journal-title': 'Oral Diseases', 'key': 'e_1_2_7_3_1', 'year': '2020'}, {'DOI': '10.1016/j.jinf.2020.04.005', 'doi-asserted-by': 'publisher', 'key': 'e_1_2_7_4_1'}, {'DOI': '10.1007/s40121-018-0200-7', 'doi-asserted-by': 'publisher', 'key': 'e_1_2_7_5_1'}, {'DOI': '10.1159/000089211', 'doi-asserted-by': 'publisher', 'key': 'e_1_2_7_6_1'}, { 'article-title': 'Guidelines for infection control in dental health‐care settings–2003', 'author': 'Kohn W. G.', 'first-page': '1', 'issue': '17', 'journal-title': 'MMWR ‐ Recommendations and Reports', 'key': 'e_1_2_7_7_1', 'volume': '52', 'year': '2003'}, { 'DOI': '10.1016/S0140-6736(20)30251-8', 'doi-asserted-by': 'publisher', 'key': 'e_1_2_7_8_1'}, {'DOI': '10.1093/function/zqaa002', 'doi-asserted-by': 'publisher', 'key': 'e_1_2_7_9_1'}, {'DOI': '10.1038/s41368-020-0075-9', 'doi-asserted-by': 'publisher', 'key': 'e_1_2_7_10_1'}, { 'DOI': '10.1016/S1473-3099(20)30196-1', 'doi-asserted-by': 'publisher', 'key': 'e_1_2_7_11_1'}, { 'article-title': 'Consistent detection of 2019 novel coronavirus in saliva', 'author': 'To K. K.', 'first-page': '1', 'journal-title': 'Clinical Infectious Diseases', 'key': 'e_1_2_7_12_1', 'year': '2020'}, { 'DOI': '10.1016/j.ijid.2020.05.030', 'doi-asserted-by': 'publisher', 'key': 'e_1_2_7_13_1'}], 'reference-count': 12, 'references-count': 12, 'relation': {}, 'resource': {'primary': {'URL': 'https://onlinelibrary.wiley.com/doi/10.1111/odi.13526'}}, 'score': 1, 'short-title': [], 'source': 'Crossref', 'subject': [], 'subtitle': [], 'title': 'Is povidone iodine mouthwash effective against SARS‐CoV‐2? First in vivo tests', 'type': 'journal-article', 'update-policy': 'http://dx.doi.org/10.1002/crossmark_policy', 'volume': '28'}
Loading..
Please send us corrections, updates, or comments. c19early involves the extraction of 100,000+ datapoints from thousands of papers. Community updates help ensure high accuracy. Treatments and other interventions are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop   
Submit